Atlas Trials

Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

Clinical trial NCT04309773 · UNKNOWN

Trial details

NCT number
NCT04309773
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Sclerosing CholangitisCholestasis
Start date
2021-04-06
Primary completion
2023-03-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.